Effects of High-Resistance Inspiratory Muscle Strength Training on Cardiorenal and Vascular Function in Youth and Young Adults With Type 2 Diabetes
Launched by SEATTLE CHILDREN'S HOSPITAL · Apr 14, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new exercise called high-resistance inspiratory muscle strength training (IMST) to see how it affects young people with Type 2 diabetes (T2D). IMST involves taking 30 strong breaths against a resistance, which only takes about 5 minutes a day. Researchers want to find out if this training can improve heart and kidney function, blood pressure, and other health markers in youth and young adults with T2D over three months.
To participate in this study, you need to be between 14 and 40 years old and have had Type 2 diabetes for at least one year, with a blood sugar level (measured by HbA1C) below 12%. However, if you have had diabetes for more than 18 years, have certain kidney issues, or high blood pressure, you might not be eligible. If you join the study, you will either do the IMST or a similar, non-active training, and researchers will monitor your health changes throughout the trial. This study is not yet recruiting participants, but it offers a simple and short daily activity that could potentially improve health for young people living with diabetes.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: Aged 14-40, have had T2D for a least one year, HbA1C less than 12%.
- • -
- • Exclusion Criteria: Have had type II diabetes for more than 18 years, estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73m2 or Albumin-to-creatinine ratio (ACR) greater than 2200mg/g, blood pressure greater than 160/100 mm Hg.
- • -
About Seattle Children's Hospital
Seattle Children's Hospital is a leading pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital focuses on developing new treatments and therapies that address the unique medical needs of children. With a commitment to excellence, Seattle Children's Hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to ensure rigorous scientific standards and ethical practices in all its clinical investigations. By prioritizing patient safety and scientific integrity, the hospital aims to contribute to the global body of knowledge in pediatric medicine and improve outcomes for children with various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Seattle, Washington, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported